Journal of the Korean Association of Oral and Maxillofacial Surgeons

  • 제43권6호
  • /
  • Pages.373-387
  • /
  • 2017
  • /
  • 2234-7550(pISSN)
  • /
  • 2234-5930(eISSN)
대한구강악안면외과학회 (The Korean Association of Oral and Maxillofacial Surgeons)
권호 표지
DOI QR코드

DOI QR Code

Stepwise verification of bone regeneration using recombinant human bone morphogenetic protein-2 in rat fibula model

  • Nam, Jung-Woo (Department of Oral and Maxillofacial Surgery, Yonsei University College of Dentistry) ;
  • Kim, Hyung-Jun (Department of Oral and Maxillofacial Surgery, Yonsei University College of Dentistry)
  • 투고 : 2017.07.22
  • 심사 : 2017.09.20
  • 발행 : 2017.12.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Objectives: The purpose of this study was to introduce our three experiments on bone morphogenetic protein (BMP) and its carriers performed using the critical sized segmental defect (CSD) model in rat fibula and to investigate development of animal models and carriers for more effective bone regeneration. Materials and Methods: For the experiments, 14, 16, and 24 rats with CSDs on both fibulae were used in Experiments 1, 2, and 3, respectively. BMP-2 with absorbable collagen sponge (ACS) (Experiments 1 and 2), autoclaved autogenous bone (AAB) and fibrin glue (FG) (Experiment 3), and xenogenic bone (Experiment 2) were used in the experimental groups. Radiographic and histomorphological evaluations were performed during the follow-up period of each experiment. Results: Significant new bone formation was commonly observed in all experimental groups using BMP-2 compared to control and xenograft (porcine bone) groups. Although there was some difference based on BMP carrier, regenerated bone volume was typically reduced by remodeling after initially forming excessive bone. Conclusion: BMP-2 demonstrates excellent ability for bone regeneration because of its osteoinductivity, but efficacy can be significantly different depending on its delivery system. ACS and FG showed relatively good bone regeneration capacity, satisfying the essential conditions of localization and release-control when used as BMP carriers. AAB could not provide release-control as a BMP carrier, but its space-maintenance role was remarkable. Carriers and scaffolds that can provide sufficient support to the BMP/carrier complex are necessary for large bone defects, and AAB is thought to be able to act as an effective scaffold. The CSD model of rat fibula is simple and useful for initial estimate of bone regeneration by agents including BMPs.

키워드

참고문헌

  1. Boyne PJ. Osseous reconstruction of the maxilla and the mandible: surgical techniques using titanium mesh and bone mineral. Implant Dentistry 1998;7:378-9.
  2. Hausamen JE, Neukam FW. Transplantation of bones. Eur Arch Otorhinolaryngol Suppl 1992;1:163-77.
  3. Hopp SG, Dahners LE, Gilbert JA. A study of the mechanical strength of long bone defects treated with various bone autograft substitutes: an experimental investigation in the rabbit. J Orthop Res 1989;7:579-84. https://doi.org/10.1002/jor.1100070416
  4. Dickinson BP, Ashley RK, Wasson KL, O'Hara C, Gabbay J, Heller JB, et al. Reduced morbidity and improved healing with bone morphogenic protein-2 in older patients with alveolar cleft defects. Plast Reconstr Surg 2008;121:209-17. https://doi.org/10.1097/01.prs.0000293870.64781.12
  5. Fallucco MA, Carstens MH. Primary reconstruction of alveolar clefts using recombinant human bone morphogenic protein-2: clinical and radiographic outcomes. J Craniofac Surg 2009;20 Suppl 2:1759-64. https://doi.org/10.1097/SCS.0b013e3181b5d08e
  6. Herford AS. rhBMP-2 as an option for reconstructing mandibular continuity defects. J Oral Maxillofac Surg 2009;67:2679-84. https://doi.org/10.1016/j.joms.2009.07.096
  7. Herford AS, Boyne PJ. Reconstruction of mandibular continuity defects with bone morphogenetic protein-2 (rhBMP-2). J Oral Maxillofac Surg 2008;66:616-24. https://doi.org/10.1016/j.joms.2007.11.021
  8. Hollinger JO, Kleinschmidt JC. The critical size defect as an experimental model to test bone repair materials. J Craniofac Surg 1990;1:60-8. https://doi.org/10.1097/00001665-199001000-00011
  9. Mapara M, Thomas BS, Bhat KM. Rabbit as an animal model for experimental research. Dent Res J (Isfahan) 2012;9:111-8. https://doi.org/10.4103/1735-3327.92960
  10. Choi EJ, Kang SH, Kwon HJ, Cho SW, Kim HJ. Bone healing properties of autoclaved autogenous bone grafts incorporating recombinant human bone morphogenetic protein-2 and comparison of two delivery systems in a segmental rabbit radius defect. Maxillofac Plast Reconstr Surg 2014;36:94-102. https://doi.org/10.14402/jkamprs.2014.36.3.94
  11. Boyne PJ, Marx RE, Nevins M, Triplett G, Lazaro E, Lilly LC, et al. A feasibility study evaluating rhBMP-2/absorbable collagen sponge for maxillary sinus floor augmentation. Int J Periodontics Restorative Dent 1997;17:11-25.
  12. Lee JH, Kim CS, Choi KH, Jung UW, Yun JH, Choi SH, et al. The induction of bone formation in rat calvarial defects and subcutaneous tissues by recombinant human BMP-2, produced in Escherichia coli. Biomaterials 2010;31:3512-9. https://doi.org/10.1016/j.biomaterials.2010.01.075
  13. McKay WF, Peckham SM, Badura JM. A comprehensive clinical review of recombinant human bone morphogenetic protein-2 (INFUSE Bone Graft). Int Orthop 2007;31:729-34. https://doi.org/10.1007/s00264-007-0418-6
  14. Kubler NR, Reuther JF, Faller G, Kirchner T, Ruppert R, Sebald W. Inductive properties of recombinant human BMP-2 produced in a bacterial expression system. Int J Oral Maxillofac Surg 1998;27:305-9. https://doi.org/10.1016/S0901-5027(05)80621-6
  15. Haidar ZS, Hamdy RC, Tabrizian M. Delivery of recombinant bone morphogenetic proteins for bone regeneration and repair. Part A: current challenges in BMP delivery. Biotechnol Lett 2009;31:1817-24. https://doi.org/10.1007/s10529-009-0099-x
  16. Haidar ZS, Hamdy RC, Tabrizian M. Delivery of recombinant bone morphogenetic proteins for bone regeneration and repair. Part B: delivery systems for BMPs in orthopaedic and craniofacial tissue engineering. Biotechnol Lett 2009;31:1825-35. https://doi.org/10.1007/s10529-009-0100-8
  17. Issa JP, Bentley MV, Iyomasa MM, Sebald W, De Albuquerque RF. Sustained release carriers used to delivery bone morphogenetic proteins in the bone healing process. Anat Histol Embryol 2008;37:181-7. https://doi.org/10.1111/j.1439-0264.2007.00824.x
  18. Jung RE, Weber FE, Thoma DS, Ehrbar M, Cochran DL, Hammerle CH. Bone morphogenetic protein-2 enhances bone formation when delivered by a synthetic matrix containing hydroxyapatite/tricalciumphosphate. Clin Oral Implants Res 2008;19:188-95. https://doi.org/10.1111/j.1600-0501.2007.01431.x
  19. Wikesjo UM, Qahash M, Huang YH, Xiropaidis A, Polimeni G, Susin C. Bone morphogenetic proteins for periodontal and alveolar indications; biological observations--clinical implications. Orthod Craniofac Res 2009;12:263-70. https://doi.org/10.1111/j.1601-6343.2009.01461.x
  20. Han DK, Kim CS, Jung UW, Chai JK, Choi SH, Kim CK, et al. Effect of a fibrin-fibronectin sealing system as a carrier for recombinant human bone morphogenetic protein-4 on bone formation in rat calvarial defects. J Periodontol 2005;76:2216-22. https://doi.org/10.1902/jop.2005.76.12.2216
  21. Hong SJ, Kim CS, Han DK, Cho IH, Jung UW, Choi SH, et al. The effect of a fibrin-fibronectin/beta-tricalcium phosphate/recombinant human bone morphogenetic protein-2 system on bone formation in rat calvarial defects. Biomaterials 2006;27:3810-6. https://doi.org/10.1016/j.biomaterials.2006.02.045
  22. Patel VV, Zhao L, Wong P, Kanim L, Bae HW, Pradhan BB, et al. Controlling bone morphogenetic protein diffusion and bone morphogenetic protein-stimulated bone growth using fibrin glue. Spine (Phila Pa 1976) 2006;31:1201-6. https://doi.org/10.1097/01.brs.0000217650.90861.99
  23. Kim HJ, Kang SW, Lim HC, Han SB, Lee JS, Prasad L, et al. The role of transforming growth factor-beta and bone morphogenetic protein with fibrin glue in healing of bone-tendon junction injury. Connect Tissue Res 2007;48:309-15. https://doi.org/10.1080/03008200701692610
  24. Patel VV, Zhao L, Wong P, Pradhan BB, Bae HW, Kanim L, et al. An in vitro and in vivo analysis of fibrin glue use to control bone morphogenetic protein diffusion and bone morphogenetic proteinstimulated bone growth. Spine J 2006;6:397-403; discussion 404. https://doi.org/10.1016/j.spinee.2005.11.006
  25. Lee JG, Lee EW. Healing process of the reimplanted autoclaved autogenous mandible in adult dogs. J Korean Assoc Oral Maxillofac Surg 1993;19:514-32.
  26. Bohm P, Springfeld R, Springer H. Re-implantation of autoclaved bone segments in musculoskeletal tumor surgery. Clinical experience in 9 patients followed for 1.1-8.4 years and review of the literature. Arch Orthop Trauma Surg 1998;118:57-65. https://doi.org/10.1007/s004020050312
  27. Ito T, Sakano S, Sato K, Sugiura H, Iwata H, Murata Y, et al. Sensitivity of osteoinductive activity of demineralized and defatted rat femur to temperature and duration of heating. Clin Orthop Relat Res 1995;(316):267-75.
  28. Kao JT, Comstock C. Reimplantation of a contaminated and devitalized bone fragment after autoclaving in an open fracture. J Orthop Trauma 1995;9:336-40. https://doi.org/10.1097/00005131-199509040-00011
  29. Sugiura H, Yamamura S, Sato K, Katagiri H, Nishida Y, Nakashima H, et al. Remodelling and healing process of moderately heat-treated bone grafts after wide resection of bone and soft-tissue tumors. Arch Orthop Trauma Surg 2003;123:514-20. https://doi.org/10.1007/s00402-003-0556-2
  30. von Wilmowsky C, Schwarz S, Kerl JM, Srour S, Lell M, Felszeghy E, et al. Reconstruction of a mandibular defect with autogenous, autoclaved bone grafts and tissue engineering: an in vivo pilot study. J Biomed Mater Res A 2010;93:1510-8.
  31. Izawa H, Hachiya Y, Kawai T, Muramatsu K, Narita Y, Ban N, et al. The effect of heat-treated human bone morphogenetic protein on clinical implantation. Clin Orthop Relat Res 2001;(390):252-8.
  32. Smith WS, Struhl S. Replantation of an autoclaved autogenous segment of bone for treatment of chondrosarcoma. Long-term follow up. J Bone Joint Surg Am 1988;70:70-5. https://doi.org/10.2106/00004623-198870010-00011
  33. Shimizu K, Masumi S, Yano H, Fukunaga T, Ikebe S, Shin S. Revascularization and new bone formation in heat-treated bone grafts. Arch Orthop Trauma Surg 1999;119:57-61. https://doi.org/10.1007/s004020050355
  34. Shin S, Yano H, Fukunaga T, Ikebe S, Shimizu K, Kaku N, et al. Biomechanical properties of heat-treated bone grafts. Arch Orthop Trauma Surg 2005;125:1-5. https://doi.org/10.1007/s00402-004-0746-6
  35. Crespi R, Cappare P, Gherlone E. Comparison of magnesium-enriched hydroxyapatite and porcine bone in human extraction socket healing: a histologic and histomorphometric evaluation. Int J Oral Maxillofac Implants 2011;26:1057-62.
  36. Scarano A, Piattelli A, Perrotti V, Manzon L, Iezzi G. Maxillary sinus augmentation in humans using cortical porcine bone: a histological and histomorphometrical evaluation after 4 and 6 months. Clin Implant Dent Relat Res 2011;13:13-8. https://doi.org/10.1111/j.1708-8208.2009.00176.x
  37. Figueiredo M, Henriques J, Martins G, Guerra F, Judas F, Figueiredo H. Physicochemical characterization of biomaterials commonly used in dentistry as bone substitutes--comparison with human bone. J Biomed Mater Res B Appl Biomater 2010;92:409-19.

피인용 문헌

  1. Escherichia coli BMP-2 showed comparable osteoinductivity with Chinese hamster ovary derived BMP-2 with demineralized bone matrix as carrier vol.37, pp.1, 2017, https://doi.org/10.1080/08977194.2019.1596905
  2. Recombinant Human Bone Growth Factor BMP-2 Produced in Escherichia coli. Part 1: From Protein Purification to Experimental Models for Efficacy Research vol.35, pp.1, 2017, https://doi.org/10.3103/s0891416820010036